Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]

Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] was reported 104 times

These side effects are most commonly reported by patients taking drugs of the Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] class:

# Drug class Count
0 DRUG RESISTANCE 19
1 HEADACHE 14
2 NAUSEA 14
3 FATIGUE 12
4 DIARRHOEA 10
5 ACUTE KIDNEY INJURY 6
6 ALANINE AMINOTRANSFERASE INCREASED 6
7 DECREASED APPETITE 5
8 OFF LABEL USE 5
9 ABDOMINAL PAIN 4
10 DIZZINESS 4
11 DRUG INEFFECTIVE 4
12 SKIN LESION 4
13 VOMITING 4
14 ABDOMINAL DISCOMFORT 3
15 HEPATIC CYTOLYSIS 3
16 MONKEYPOX 3
17 PRURITUS 3
18 BACK PAIN 2
19 CD4 LYMPHOCYTES DECREASED 2
20 CHEST DISCOMFORT 2
21 CHILLS 2
22 CONDITION AGGRAVATED 2
23 DRUG INTERACTION 2
24 HYPERSENSITIVITY 2
25 INCORRECT PRODUCT ADMINISTRATION DURATION 2
26 NEUTROPENIA 2
27 NEUTROPHIL COUNT DECREASED 2
28 OSTEOMYELITIS 2
29 PAIN 2
30 PARAESTHESIA 2
31 RENAL FAILURE 2
32 SEPTIC SHOCK 2
33 SHOCK HAEMORRHAGIC 2
34 TRANSAMINASES INCREASED 2
35 TREATMENT FAILURE 2
36 URINARY RETENTION 2
37 ACUTE RESPIRATORY FAILURE 1
38 AGRANULOCYTOSIS 1
39 ANORECTAL DISCOMFORT 1
40 ASPARTATE AMINOTRANSFERASE INCREASED 1
41 BLOOD ALBUMIN DECREASED 1
42 BLOOD BICARBONATE INCREASED 1
43 BLOOD BILIRUBIN DECREASED 1
44 BLOOD CALCIUM DECREASED 1
45 BLOOD CREATININE INCREASED 1
46 BLOOD PRESSURE INCREASED 1
47 BRAIN FOG 1
48 BURNING SENSATION 1
49 CARDIO-RESPIRATORY ARREST 1
50 CONSTIPATION 1
51 CYTOMEGALOVIRUS VIRAEMIA 1
52 DEATH 1
53 DISEASE PROGRESSION 1
54 DISTURBANCE IN ATTENTION 1
55 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
56 DRUG LEVEL FLUCTUATING 1
57 DRUG RESISTANCE MUTATION 1
58 DRY SKIN 1
59 DUODENAL ULCER HAEMORRHAGE 1
60 DYSPEPSIA 1
61 DYSPHAGIA 1
62 DYSURIA 1
63 EOSINOPHILIA 1
64 FUNGAEMIA 1
65 GASTROINTESTINAL HAEMORRHAGE 1
66 GASTROOESOPHAGEAL REFLUX DISEASE 1
67 GENERALISED TONIC-CLONIC SEIZURE 1
68 HAEMATOCHEZIA 1
69 HAEMATOCRIT DECREASED 1
70 HAEMOGLOBIN DECREASED 1
71 HALLUCINATION 1
72 HEPATIC ENZYME INCREASED 1
73 HEPATOCELLULAR INJURY 1
74 HYPERHIDROSIS 1
75 HYPERKALAEMIA 1
76 HYPERTRANSAMINASAEMIA 1
77 HYPOAESTHESIA 1
78 HYPOXIA 1
79 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1
80 INFUSION RELATED REACTION 1
81 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1
82 INTENTIONAL DOSE OMISSION 1
83 INTENTIONAL PRODUCT USE ISSUE 1
84 IRRITABILITY 1
85 JUGULAR VEIN THROMBOSIS 1
86 KLEBSIELLA BACTERAEMIA 1
87 LOWER GASTROINTESTINAL HAEMORRHAGE 1
88 LYMPHOCYTE COUNT DECREASED 1
89 MONOCYTE COUNT DECREASED 1
90 MONOCYTOSIS 1
91 MUSCULAR WEAKNESS 1
92 MYALGIA 1
93 MYELITIS TRANSVERSE 1
94 NIGHTMARE 1
95 NODULE 1
96 ONYCHOCLASIS 1
97 PALPITATIONS 1
98 PERITONSILLAR ABSCESS 1
99 PRESCRIBED OVERDOSE 1
100 PROCTALGIA 1
101 PROCTITIS 1
102 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
103 PRODUCT PRESCRIBING ISSUE 1
104 PRODUCT USE ISSUE 1
105 PROTEIN ALBUMIN RATIO DECREASED 1
106 PSYCHOTIC DISORDER 1
107 RASH 1
108 RASH MORBILLIFORM 1
109 RECTAL HAEMORRHAGE 1
110 RED BLOOD CELL COUNT DECREASED 1
111 RESTLESS LEGS SYNDROME 1
112 SKIN ULCER 1
113 SLEEP DISORDER 1
114 SLEEP PARALYSIS 1
115 SOMNOLENCE 1
116 STEATORRHOEA 1
117 SUICIDAL IDEATION 1
118 SUPERINFECTION BACTERIAL 1
119 THROMBOCYTOPENIA 1
120 TREMOR 1
121 UNDERDOSE 1
122 URTICARIA 1
123 VACCINATION SITE INJURY 1
124 VISION BLURRED 1